Blood products, including red blood cells and platelets, are scarce and valuable resources that demand careful allocation and utilization, particularly in the context of terminally ill patients. The decision-making process for transfusions in these cases is complex and requires a nuanced approach that balances ethical principles with individual patient needs. Learn more with Dr. Lauren Smith.